Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6) [Phase 3]

View source ↗

Summary

A Phase 3 trial (STRIDE-6) evaluating the safety, tolerability, and immunogenicity of the V116 pneumococcal vaccine in adults with prior pneumococcal exposure h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease
• Pneumonia

Drugs mentioned

• V116

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumonia, Pneumococcal | Phase 3 | Status: COMPLETED | Results posted: 2024-05-01